Trustmark National Bank Trust Department Gilead Sciences, Inc. Transaction History

Trustmark National Bank Trust Department

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $165,807 - $208,473	-2,670 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $193,147 - $224,280	2,670 New	2,670 $205,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $76,887 - $84,870	-1,230 Closed	0 $0
Q3 2018 Feb 22, 2019	SELL	$71.28 - $78.92 $267,228 - $295,871	-3,749 Reduced 75.3%	1,230 $95,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $354,903 - $392,942	4,979 New	4,979 $384,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

Stay updated on Trustmark National Bank Trust Department with notifications on news.